--- title: "Pre-market hot trades in US stocks: Lunai Bioworks pre-market down 13.13%; NuScale Power pre-market up 9.39%" type: "News" locale: "en" url: "https://longbridge.com/en/news/282970969.md" description: "Lunai Bioworks pre-market down 13.13%; NuScale Power pre-market up 9.39%; Cheetah Net Supply Chain pre-market up 134.68%; Myseum pre-market up 122.85%; Meiwutek Technology pre-market up 64.03%" datetime: "2026-04-16T09:17:53.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/282970969.md) - [en](https://longbridge.com/en/news/282970969.md) - [zh-HK](https://longbridge.com/zh-HK/news/282970969.md) --- # Pre-market hot trades in US stocks: Lunai Bioworks pre-market down 13.13%; NuScale Power pre-market up 9.39% **Popular Pre-Market Trades in US Stocks** Lunai Bioworks is down 13.13% in pre-market trading. Based on recent key news: 1. On April 15, Lunai Bioworks signed a letter of intent with Geneial to establish a cohort for patients with rare diseases to promote collaboration with pharmaceutical companies. This initiative aims to form a clinical trial cohort through patient data, driving drug development and commercial collaboration, which is expected to lead to revenue growth. However, the market remains cautious about the actual effects of the collaboration, resulting in a pre-market drop of 13.13%. Source: PR Newswire 2. On April 15, Lunai Bioworks released a press release detailing the content and goals of the collaboration plan. The company emphasized its focus on integrating rare disease datasets and advancing collaboration opportunities with pharmaceutical companies. Although this news indicates potential growth opportunities, investors still have doubts about short-term gains, affecting stock performance. Source: Public Technologies 3. On April 15, the formation of partnerships aims to transform the data provided by patients into clinical trial-ready cohorts to support drug development and commercial collaboration. The market is cautiously optimistic about the long-term impact of this collaboration, leading to stock price fluctuations. Source: Public Technologies Opportunities for collaboration in the rare disease field are increasing, with the market remaining watchful. NuScale Power is up 9.39% in pre-market trading. Based on recent key news: 1. On April 15, NuScale Power released a new company announcement that may involve future business development plans, driving the stock price up. The announcement was published via PR Newswire, indicating the company's positive outlook for the future. 2. On April 13, Fluor Corporation sold a portion of its shares in NuScale Power, leading to increased market attention on the company's equity structure. Fluor sold 13.5 million shares at a price of $12.07 per share. 3. On April 15, NuScale Power is facing a collective securities lawsuit involving personal liability claims against two executives. This legal action may affect investor confidence, although the stock price remains strong in pre-market trading. The nuclear energy industry is recovering, and the market is focused on potential opportunities. **Top Gainers in Pre-Market Trading for US Stocks** Cheetah Net Supply Chain is up 134.68% in pre-market trading, with no significant news recently. Trading is active, and there is a clear flow of funds. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Myseum is up 122.85% in pre-market trading. Based on recent key news: 1. On April 15, Myseum announced its name change to Myseum.AI, integrating artificial intelligence technology. This move has attracted market attention, leading to a substantial increase in stock price during pre-market trading 2. On April 16th, Myseum.AI's stock price rose over 135% in pre-market trading, as the company announced it would focus on developing privacy-first personalized AI assistants, further boosting market confidence. 3. On April 16th, Myseum.AI's stock price had fallen over 35% in the past year, but news of the brand overhaul and technology integration drove a rebound in the stock price. The technology industry is reshaping brands, and AI integration is drawing attention. Meiwu Technology, up 64.03% in pre-market, has had no significant news recently. Trading is active, with clear capital flows. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation ### Related Stocks - [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md) - [SMR.US](https://longbridge.com/en/quote/SMR.US.md) ## Related News & Research - [Prediction: NuScale Power stock is a buy before 2027 due to this $1.75 trillion opportunity](https://longbridge.com/en/news/286646853.md) - [AI face is taking over — and driving plastic surgeons crazy](https://longbridge.com/en/news/286641783.md) - [How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here](https://longbridge.com/en/news/286786866.md) - [ZAWYA: SAS expands SAS Viya with governed AI assistants and agentic AI capabilities](https://longbridge.com/en/news/286747394.md) - [Intelligent Protection Management Corp. Launches IPM Private Cloud AI Offering | IPM Stock News](https://longbridge.com/en/news/286896871.md)